Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Ofirmev vs Toradol for ED Headache
NCT03472872Phase 4Withdrawn
- Sponsor
- Corewell Health
- Start
- Sep 2017
- Primary completion
- Jun 2020
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 4, randomised, double-blind trial of acetaminophen and ketorolac in Headache, sponsored by Corewell Health. Primary endpoint: Pain Improvement at 60 minutes. Planned start Sep 2017; status: withdrawn.
02
Drugs
acetaminophenketorolac
03
Conditions
Headache
Beyond the preview
Go deeper on NCT03472872.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT03472872.